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There was no significant difference in the EQ-VAS suggesting it may not be representative of foot and ankle health. Health economics analysis using the EQ-5D-5L data to estimate quality-4 adjusted life years (QALYs) suggested all three procedures were favourable compared to threshold levels of cost-effectiveness. There were differences in estimated costs between the three operations with AF at £2950 (threshold cost <£5,400) and MF at £1197 (threshold cost <£5,780) and HV varying from £625 to £1688 (threshold cost <£1640).
This study reveals that the joint-specific (MOX-FQ) and generic health (EQ-5D-5L) outcome scores of patients improved after AF, MF and HV. The greatest benefit from surgery was gained in the arthritic patient groups. In the future, the use of large population patient reported outcome measures data may also potentially have implications for prioritisation of healthcare provision, acting as an indicator of foot and ankle surgical procedures that produce the most benefit to patients. This study has also included HV as it is probably the commonest patient group in foot and ankle surgery.
Many scoring systems exist which relate specifically to the foot and ankle. One study found Institute for Health and Care Excellence (NICE) (13) recommends that EuroQol EQ-5D (14) is used to estimate QALYs. The QALY can be calculated using the area-under-curve method (15) with linear interpolation (this assumes a straight-line change between points, rather than an immediate improvement). In line with previous work (16), we estimated the QALY gain between the individual pre-and post-operation EQ-5D-5L scores, based on the assumption of a 6 month follow up period and that without the procedure in question the pre-operative score would have been maintained (see Appendix 1). Threshold analysis (12) was then conducted on the mean QALY gain for each procedure in order to estimate the maximum cost at which the procedure is likely to be cost-effective based on the threshold value of £20000 per QALY (13). Indicative costs were subsequently identified for each procedure and compared to these maximum costs in order to assess whether the procedures were likely to have favourable levels of cost-effectiveness.
A one-way ANOVA was used for between groups statistical analysis, and a paired student's t-test for the pre-and post-operative score analysis. A p-value of <0.05 was accepted as being statistically significant. Local audit committee approval was obtained for the study.
RESULTS
In total 143 patients referred to the Norfolk and Norwich University Hospital received one of the three procedures in the study time period. After application of the exclusion criteria 85 8 patients were identified (figure 1). 76 patients had completed pre-operative questionnaires, and 63 of these went on to complete MOXFQ and EQ-5D post-operative questionnaires at a median of 12 months following surgery (range 6-24 months). However all data from the 76 patients completing pre-operative questionnaires was used in statistical analysis. The average age was 59 years (range 26-85 years) and 53 (70%) patients were female (table 1).
The HV group was mainly female and had a wider age range compared to the AF and MF groups.
MOX-FQ
Mean pre-operative MOX-FQ scores were AF 53. hallux valgus p=0.0027). Post-operative EQ-5D-5L did not differ between groups (p=0.0678).
EQ-VAS
The EQ-VAS showed a significant difference between the surgical groups pre-operatively (Table 2) .
Clinical Outcomes
None of the patients in the study population underwent revision surgery or had removal of metalwork during the study period. A total of 4 out of the 22 AF patients had post operative computer tomography (CT) scans for ongoing pain. Two had non unions and two had solid fusions. One AF patient sustained a stress fracture at the proximal screw four months postoperatively. This was managed conservatively and healed by 7 months post-operation.
There were no MF non-unions, although one patient with a poor MOX-FQ score had a CT scan demonstrating union.
Health Economics
Threshold analysis was used to determine the cost below that an intervention would look to have a favourable cost per QALY, given the estimated QALY gain [12] (Table 3) . NICE recommends a cost of £20,000 per QALY.
For the cost of the intervention in England the NHS National Schedule of Reference Costs 2013-14 was used (Table 4 For AF there is a cost of £2950 and in this study's patient group a QALY gain of 0.270
(compared to what would have happened without the intervention). As the incremental cost of the intervention is <£5,400 then the cost per QALY is likely to be favourable.
For MF there is a cost of £1197 and in this study's patient group a QALY gain of 0.289
(compared to what would have happened without the intervention). As the incremental cost of the intervention is <£5,780 then the cost per QALY is likely to be favourable.
For HV the costing is not as clear due to the variations in surgery and coding requirements.
OPCS-4 and HRG4 codes stipulate if a soft tissue procedure is performed with hallux valgus surgery then this code has to be listed first. This leads to a considerable reduction in the costing. For hallux valgus surgery there is a cost ranging from £625 to £1688 and in this study's patient group a QALY gain of 0.082 (compared to what would have happened without the intervention). As the incremental cost of the intervention, £1640, is similar to the top end cost then the cost per QALY is just likely to be favourable.
DISCUSSION
The results of this study show that both foot and ankle specific (MOX-FQ), and generic (EQ-5D-5L) scores differ between patients who have different pathologies of the foot and ankle.
Arthritic conditions affecting the ankle joint (AF group) lead to the worst MOX-FQ and EQ-5D-5L scores followed by arthritis of the first MTP joint (MF group), with hallux valgus patients (HV group) recording the best scores of the three study groups. Both MOX-FQ and EQ-5D-5L show a statistically significant improvement following surgery in the three groups.
These results are broadly in line with previous studies which have suggested that the MOXFQ is the best disease-specific score for hallux valgus patients (17) , and that it is more responsive in foot and ankle patients than EQ-5D-5L and other generic scoring systems (18).
The minimum change for a MOX-FQ score to be considered significant is 7 points (19) . In this study, the mean change in each of the three groups was greater than 7. However, there were ten patients who did not achieve this level: 3 AF, 2 MF and 5 HV. The EQ-VAS showed a difference in pre operative scores, but there was no significant change from pre-op to postop in any of the three groups (the post operative scores did not differ significantly between the groups). This suggests the EQ-VAS may not be responsive to foot and ankle health.
Patients may perceive their overall health as representing something different than a specific problem related to foot and ankle pain and mobility.
From the health economics analysis using the EQ-5D-5L the three interventions can be judged to be cost-effective procedures. Hallux valgus surgery emerges as having a cost that is similar to the threshold cost. However coding requirements demand if a soft tissue procedure is involved then this has to be coded first. This leads to the cost of the procedure to be much less than the threshold cost. Most surgeons would agree that a first metatarsal osteotomy for hallux valgus always requires release of the tight lateral tissue and reefing of the medial soft tissues. Therefore all hallux valgus surgery will be coded at a lower cost.
There are a number of potential criticisms of this analysis. It is assumed the quality of life would not have changed without intervention. For the three interventions listed surgery is only advised when patients are unable to manage their symptoms with painkillers, altered footwear or altered activities. All three conditions have a slow onset and it is likely patients have lived with their symptoms for sometime prior to presentation. The three conditions affect mobility and unless the patients stop walking (highly unlikely) they are likely to have continued symptoms without an intervention. For these interventions only the cost associated with the initial procedure have been considered. Other costs e.g. physiotherapy and medication costs, might differ between groups and the analysis makes the assumption that all other costs are the same in both groups. Though this might be a simplification it is recognised that cost-effectiveness studies should concentrate on those resources that are expected to differ between groups, and that healthcare resource groupings are often used to estimate unit costs [20] .
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The limitations for this study are the relatively small number of patients with a variable follow up. There is a risk of bias from the patients lost to follow up. In total 63 out of the 76 (83%) patients meeting the inclusion criteria with pre-operative data were contactable for post-operative scores. Excluding those patients who had rheumatoid arthritis, multiple surgical procedures, revision procedures and bilateral procedures strengthens the study enabling the particular disease process to be studied in isolation.
Patient reported outcome measures are undoubtedly of use for clinical audit, quality improvement, and identification of surgeon outliers (21, 22) . However, the quality of their measurement properties (23) , and hence their use in rationalising surgical services and predicting patients' post-operative outcomes have been shown to be limited for other orthopaedic conditions (24) ; this is also likely to be the case for foot and ankle conditions.
Further research needs to be undertaken to ascertain the best outcome measure for foot and ankle patients' general health, and disease-specific health. Introduction of the proposed national database of foot and ankle outcomes will allow analysis of much larger patient numbers and more valid conclusions may then be drawn regarding the relevant benefits of various foot and ankle procedures.
CONCLUSIONS
The results in this study show that patients with arthritic conditions of the ankle (AF group) and great toe (MF group) score significantly worse pre-operatively than those with hallux valgus (HV group). Surgical management of the three conditions studied improved the patients' joint-specific (MOX-FQ) and generic health (EQ-5D-5L) outcome measures in all groups. The greatest benefit from surgery was gained in the AF and MF groups. In the 14 future, the use of large population patient reported outcome measures data will aid foot and ankle surgeons when counseling patients regarding likely post-operative outcomes, and serve to inform patients' expectations of surgery. They may also potentially have implications for prioritisation of healthcare provision, acting as an indicator of foot and ankle surgical procedures that produce the most benefit to patients. 
